IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

BAI, FRANCESCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.706
NA - Nord America 2.629
AS - Asia 1.283
SA - Sud America 143
AF - Africa 41
OC - Oceania 19
Continente sconosciuto - Info sul continente non disponibili 2
Totale 7.823
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.519
GB - Regno Unito 1.310
IT - Italia 976
CN - Cina 509
DE - Germania 455
SG - Singapore 318
SE - Svezia 208
RU - Federazione Russa 154
FR - Francia 114
IN - India 113
CA - Canada 101
BR - Brasile 99
IE - Irlanda 89
TR - Turchia 85
FI - Finlandia 81
ID - Indonesia 81
NL - Olanda 80
HK - Hong Kong 47
DK - Danimarca 32
ES - Italia 32
KR - Corea 32
UA - Ucraina 28
CH - Svizzera 25
BE - Belgio 20
AU - Australia 19
PL - Polonia 17
VN - Vietnam 17
EU - Europa 15
TW - Taiwan 15
AT - Austria 14
CO - Colombia 13
GR - Grecia 12
ZA - Sudafrica 11
AR - Argentina 9
ET - Etiopia 9
AE - Emirati Arabi Uniti 8
TH - Thailandia 8
MY - Malesia 7
PT - Portogallo 7
CZ - Repubblica Ceca 6
JP - Giappone 6
MK - Macedonia 6
MX - Messico 6
RO - Romania 6
BD - Bangladesh 5
CL - Cile 5
IR - Iran 5
NO - Norvegia 5
RS - Serbia 5
UZ - Uzbekistan 5
VE - Venezuela 5
AL - Albania 4
EC - Ecuador 4
HU - Ungheria 4
PE - Perù 4
AZ - Azerbaigian 3
BG - Bulgaria 3
BO - Bolivia 3
CD - Congo 3
EG - Egitto 3
HR - Croazia 3
MA - Marocco 3
PH - Filippine 3
PK - Pakistan 3
SC - Seychelles 3
EE - Estonia 2
KE - Kenya 2
LT - Lituania 2
LV - Lettonia 2
MO - Macao, regione amministrativa speciale della Cina 2
SA - Arabia Saudita 2
SN - Senegal 2
TN - Tunisia 2
UG - Uganda 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CR - Costa Rica 1
IL - Israele 1
IM - Isola di Man 1
IQ - Iraq 1
JM - Giamaica 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LI - Liechtenstein 1
LK - Sri Lanka 1
PA - Panama 1
PS - Palestinian Territory 1
SK - Slovacchia (Repubblica Slovacca) 1
UY - Uruguay 1
ZW - Zimbabwe 1
Totale 7.837
Salva come PNG Salva come JPEG
Città #
Southend 1.222
Chandler 333
Milan 273
Fairfield 240
Singapore 215
Frankfurt am Main 202
Ann Arbor 151
Wilmington 151
Seattle 118
Houston 110
Woodbridge 107
Princeton 100
Beijing 89
Dublin 86
Ashburn 85
Council Bluffs 77
Jakarta 71
Toronto 71
Santa Clara 69
Cambridge 62
Rome 62
Dearborn 59
Helsinki 50
New York 43
Groningen 36
Nanjing 36
Bengaluru 35
Turin 35
Hong Kong 34
Phoenix 34
Des Moines 31
Mountain View 31
Shanghai 30
Boardman 29
Istanbul 29
Redwood City 28
Grafing 23
Nuremberg 23
Cagliari 22
Guangzhou 22
Florence 21
Los Angeles 20
Redmond 20
San Diego 20
Brussels 17
Hangzhou 16
Kiez 15
Montréal 15
Mumbai 15
Berlin 14
Quanzhou 14
Fuzhou 12
Palermo 12
Shenyang 12
Warsaw 12
Hebei 11
Jacksonville 11
Munich 11
Nanchang 11
Paris 11
Roxbury 11
Silver Spring 11
Fremont 10
Jinan 10
Lappeenranta 10
Madrid 10
Sakarya 10
Vienna 10
Genoa 9
London 9
Taipei 9
Zurich 9
Andover 8
Bogotá 8
Falls Church 8
Pescara 8
Saint Petersburg 8
Seoul 8
Troia 8
Bangkok 7
Catania 7
Leonforte 7
Pontotoc 7
Acerra 6
Al Fujairah City 6
Athens 6
Bergamo 6
Chicago 6
Kent 6
Novara 6
Nürnberg 6
Taizhou 6
Vicenza 6
Washington 6
Bari 5
Brescia 5
Central District 5
Changsha 5
Clifton 5
Dong Ket 5
Totale 5.112
Salva come PNG Salva come JPEG
Nome #
HIV-ASSOCIATED NEUROCOGNITIVE DISORDERS (HAND): PERFORMANCE OF ¿3 QUESTIONS TEST¿ AS SCREENING TEST, PREVALENCE, CLINICAL CORRELATES AND THERAPEUTIC APPROACH IN THE SAN PAOLO INFECTIOUS DISEASES¿ (SPID) COHORT. 533
Efficacy and safety of dalbavancin in the treatment of acute bacterial skin and skin structure infections (ABSSSIs) and other infections in a real-life setting: data from an Italian observational multicentric study (DALBITA study). 381
Maraviroc as Intensification Strategy in HIV-1 Positive Patients with Deficient Immunological Response: an Italian Randomized Clinical Trial 277
HPV infection in a cohort of HIV-positive men and women : prevalence of oncogenic genotypes and predictors of mucosal damage at genital and oral sites 269
Reduced central memory CD4+ T cells and increased T-Cell activation characterise treatment-naive patients newly diagnosed at late stage of HIV infection 252
T-Cell Phenotypes, Apoptosis and Inflammation in HIV+ Patients on Virologically Effective cART with Early Atherosclerosis 235
Switching from efavirenz to rilpivirine improves sleep quality and self-perceived cognition but has no impact on neurocognitive performances : results from a randomized controlled trial 234
Evidence for polymicrobic flora translocating in peripheral blood of HIV-infected patients with poor immune response to antiretroviral therapy 230
Factors associated with HPV-DNA clearance in a cohort of HIV-positive patients : role of cART and gender 229
A 20-year-old girl with an unusual febrile illness 228
Circulating sCD14 is associated with virological response to pegylated-interferon-alpha/ribavirin treatment in HIV/HCV co-infected patients 212
Projections of non-communicable disease and health care costs among HIV-positive persons in Italy and the U.S.A. : a modelling study 207
Cognitive Neuro-Rehabilitation of HIV-Associated Neurocognitive Disorders : Case Reports of A New Computer-Based Restorative Approach In 3 Hiv-Positive Cart-Treated Patients 206
Assessment of radiological vertebral fractures in HIV-infected patients : clinical implications and predictive factors 192
Viro-immunological characterization of naïve patients with high cerebrospinal fluid (CSF) HIV RNA 182
Association between abdominal aortic calcifications, bone mineral density and vertebral fractures in a cohort of HIV-positive patients 179
Virological response and retention in care according to time of starting ART in Italy: Data from the Icona Foundation Study cohort 170
Sensitivity of SARS-CoV-2 Detection With Nasopharyngeal Swabs 163
Long-Term Suppressive cART Is Not Sufficient to Restore Intestinal Permeability and Gut Microbiota Compositional Changes 160
CD8+ hyperactivation and senescence correlate with early carotid intima-media thickness in HIV+ patients with no cardiovascular disease 159
Skewed T-cell maturation and function in HIV-infected patients failing CD4+ recovery upon long-term virologically suppressive HAART 158
Association between CSF and peripheral markers of immune-activation/inflammation and elevated intrathecal HIV-RNA levels in a cohort of HIV-infected antiretroviral naıve individuals 148
Clinical and viro-immunological correlates of HIV associated neurocognitive disorders (HAND) in a cohort of antiretroviral-naïve HIV-infected patients 148
Clinical effect of interleukin-2 (IL-2) immuno-adjuvant treatment in HIV+ advanced naïve patients 143
Reduced CD127 expression on peripheral CD4+ T cells impairs immunological recovery in course of suppressive HAART 137
Proportion and factors associated with recent HIV infection in a cohort of patients seen for care in Italy over 1996-2014: Data from the ICONA Foundation Study cohort 129
Long-lasting cognitive abnormalities after COVID-19 127
The impact of DAA-mediated HCV eradication on CD4+ and CD8+ T lymphocyte trajectories in HIV/HCV coinfected patients: Data from the ICONA Foundation Cohort 123
One‐Year Cognitive Follow‐Up of COVID‐19 Hospitalized Patients 121
The importance of patients’ case-mix for the correct interpretation of the hospital fatality rate in COVID-19 disease 118
Immune reconstitution in HIV+ subjects on Lopinavir/Ritonavir-based HAART according to the severity of pre-therapy CD4+ 114
One-pill once-a-day HAART: A simplification strategy that improves adherence and quality of life of HIV-infected subjects 108
Clinical characteristics and outcomes of vaccinated patients hospitalised with SARS-CoV-2 breakthrough infection: Multi-IPV, a multicentre study in Northern Italy 107
Do combination antiretroviral therapy regimens for HIV infection feature diverse T-Cell phenotypes and inflammatory profiles? 105
Declining mortality rate of hospitalised patients in the second wave of the COVID-19 epidemics in Italy : Risk factors and the age-specific patterns 98
Evolution of the prevalence of hepatitis C virus infection and hepatitis C virus genotype distribution in human immunodeficiency virus-infected patients in Italy between 1997 and 2015 97
CX3CR1 I249M280 heterozygosity is associated to contraction of HIV-specific immune responses in HIV-infected patients failing to recover CD4T-cell following long-term haart 96
CD8 T-cell activation is associated with lipodystrophy and visceral fat accumulation in antiretroviral therapy-treated virologically suppressed HIV-infected patients 93
Psychological outcomes after hospitalization for COVID-19: data from a multidisciplinary follow-up screening program for recovered patients 90
Female gender is associated with long COVID syndrome : a prospective cohort study 85
Impact of psychological intervention on anxiety, depression, and post-traumatic stress disorder: results from a longitudinal study of hospitalized Covid-19 patients = Impatto di un intervento psicologico su ansia, depressione e disturbo post-traumatico da stress: risultati di uno studio longitudinale su pazienti Covid-19 ospedalizzati 82
Prevalence of sub-clinical vertebral fractures in a cohort of HIV positive patients and ability of frax-score to identify patients at increased fracture risk 82
Anxiety and depression symptoms after virological clearance of COVID-19: A cross-sectional study in Milan, Italy 79
Real World Estimate of Vaccination Protection in Individuals Hospitalized for COVID-19 79
Effectiveness of hydroxychloroquine in COVID-19 disease : a done and dusted deal? 78
Peripheral and cerebrospinal fluid immune activation and inflammation in chronically HIV-infected patients before and after virally suppressive combination antiretroviral therapy (cART) 68
Incidence and risk factors for liver enzyme elevation among naive HIV-1-infected patients receiving ART in the ICONA cohort 62
A Quantitative Estimate of the Expected Shortening of the Median Isolation Period of Patients With COVID-19 After the Adoption of a Symptom-Based Strategy 61
Long-lasting cognitive impairment after COVID-19 60
Renal microsporidiosis due to Encephalitozoon cuniculi in an HIV/AIDS patient with persistent fever and kidney injury 56
Persistence of High Percentage of Peripheral Activated CD8+ T Cells Predict Cytologic HPV-Related Dysplasia in cART-Treated, HIV-Positive Subjects 52
Development and validation of a prediction score for failure to casirivimab/imdevimab in hospitalized patients with COVID-19 pneumonia 50
Cerebrospinal fluid HIV-1 escape according to different thresholds and underlying comorbidities : Is it time to assess the definitions? 47
Cost analysis of dalbavancin versus standard of care for the treatment of acute bacterial skin and skin structure infections (ABSSSIs) in two Italian hospitals 46
Incidence, risk factors and impact on clinical outcomes of bloodstream infections in patients hospitalised with covid-19: A prospective cohort study 36
SARS-CoV-2 mRNA Vaccine Response in People Living with HIV According to CD4 Count and CD4/CD8 Ratio 36
EuCARE-hospitalised study protocol: a cohort study of patients hospitalised with COVID-19 in the EuCARE project 35
In-hospital mortality during the wild-type, alpha, delta, and omicron SARS-CoV-2 waves: a multinational cohort study in the EuCARE project 32
EuCARE-POSTCOVID Study: a multicentre cohort study on long-term post-COVID-19 manifestations 31
Timed short messaging service improves adherence and virological outcomes in HIV-1-infected patients with suboptimal adherence to antiretroviral therapy 28
Immunologic characterization of a patient with clinical and virologic rebound upon Nirmatrelvir/Ritonavir treatment: the unfortunate epilogue of COVID-19 23
Monoclonal antibodies against SARS-CoV-2 to prevent COVID-19 worsening in a large multicenter cohort 21
null 3
null 3
Learning from post-COVID-19 condition for epidemic preparedness: a variable catalogue for future post-acute infection syndromes 2
Association between tight junction proteins and cognitive performance in untreated persons with HIV 1
Long-term outcomes of bictegravir/emtricitabine/tenofovir alafenamide as first-line therapy and as switch strategy in virologically suppressed persons with HIV: data from the ICONA cohort 1
Totale 8.197
Salva come PNG Salva come JPEG
Categoria #
all - tutte 26.897
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.897
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020291 0 0 0 0 0 0 0 0 119 115 19 38
2020/2021906 63 61 21 36 45 56 101 95 120 110 145 53
2021/20221.282 117 135 82 70 92 80 79 87 158 146 54 182
2022/20231.256 114 132 100 149 144 199 34 86 142 30 87 39
2023/20241.066 56 48 45 81 251 83 90 61 39 61 110 141
2024/20251.390 114 194 74 230 165 131 146 181 155 0 0 0
Totale 8.197